Skip to main content

Prader-Willi Syndrome clinical trials at UCSD
1 research study open to new patients

  • Cannabidiol Oral Solution for the Treatment of Subjects With Prader-Willi Syndrome

    open to eligible people ages 8-17

    The primary objective of this study is to assess the efficacy of Cannabidiol Oral Solution on hyperphagia-related behavior in subjects with Prader-Willi Syndrome (PWS). The secondary objectives of this study are to assess the efficacy, safety and tolerability, impact on quality of life, and impact on physical activity of Cannabidiol Oral Solution in subjects with PWS.

    San Diego, California and other locations

Last updated: